View this email in your browser.
JULY
17
THIS WEEK
  NEWS
  FDA Approves Novel Leukemia Treatment that Could Be First U.S. Gene Therapy
  NEWS
  Late-breaking Mutations May Play an Important Role in Autism
  NEWS
  Genome Therapy Could Lead to New Treatment for Life-threatening Blood Disorders
  NEWS
  Scientists Link New Cancer Treatments to Cardiovascular Alterations
  NEWS
  New Test Paves Way for Potential Treatments to Target Alzheimer's

Register Now

Due to intense interest from the global lab design community, the Laboratory Design Conference has launched an international lab design conference to connect professionals from around the globe. This unique educational event provides the boldest and brightest innovators in lab design with a dedicated forum to collaborate, network and learn from one another.

LEARN MORE
 
FEATURED STORY

Biomarker Data Management: A New Foundation for Insights from Translational Research

Featured Story

Delivering on the promise of precision medicine requires new approaches and informatics platforms to address new challenges.


Share Facebook Twitter Google+ LinkedIn StumbleUpon

FULL STORY
 
 

High Throughput Biological Sample Collection and Processing

Integra Biosciences

A new family of multichannel electronic pipettes is closing the gap between traditional manual pipettes and robotic systems. This new video will provide you with an informative insight into how to improve your biological sample processing and collection.


LEARN MORE
 
 
NEWS

FDA Approves Novel Leukemia Treatment that Could Be First U.S. Gene Therapy

Thumbnail

A treatment for a common childhood blood cancer could become the first gene therapy available in the U.S.


FULL STORY
 
 
NEWS

Scientists Link New Cancer Treatments to Cardiovascular Alterations

Thumbnail

A new study suggests that prolonged use of Plk1 inhibitors, which are currently in clinical trials with patients, can not only lead to hypertension issues but also to the rupturing of blood vessels and severe cardiovascular problems.


FULL STORY
 
 

Sample Preparation for the Detection of Synthetic Analogues of Insulin in Human Serum

Genevac LTD

Due to an increase in the abuse of synthetic insulins, doping laboratories require faster and more consistent testing options. The methodology to detect and confirm the presence of peptide hormones by mass spectrometry is preferred to the current use of immunoassays or other immuno-reactive techniques. This white paper explores and compares the different available methods, revealing the fastest and most accurate options for synthetic insulin detection.


DOWNLOAD NOW
 
 
FOCUS ON:

Quality-assured containers

Thumbnail

For the rigorous requirements of molecular biology, genomic and forensic research facilities, new universal containers are specifically lot tested and certified to be free from RNase, DNase, human DNA and pyrogens.


FULL STORY
 
 
NEWS

Genome Therapy Could Lead to New Treatment for Life-threatening Blood Disorders

Thumbnail

Genome therapy with beneficial natural mutation could lead to new treatment for life-threatening blood disorders.


FULL STORY
 
 
NEWS

New Technology to Manipulate Cells Could Help Treat Parkinson's, Arthritis, Other Diseases

Thumbnail

A groundbreaking advancement in materials could potentially help patients requiring stem cell therapies for spinal cord injuries, stroke, Parkinson's disease, Alzheimer's disease, arthritic joints or any other condition requiring tissue regeneration, according to a new study.


FULL STORY
 
 
NEWS

New Test Paves Way for Potential Treatments to Target Alzheimer's

Thumbnail

A simple methodology for capturing proteins implicated in the development of Alzheimer's disease and other conditions has been developed by researchers.


FULL STORY
 
 
NEWS

Late-breaking Mutations May Play an Important Role in Autism

Thumbnail

A study of nearly 6,000 families, combining three genetic sequencing technologies, finds that mutations that occur after conception play an important role in autism.


FULL STORY
 
Bioscience Technology
Facebook Twitter
SUBSCRIBE | ABOUT US | ADVERTISE
We respect your right to privacy - view our policy here.
This mailbox is unattended, so please do not reply to this message. Contact us for assistance.
If you no longer wish to receive these emails - unsubscribe here.
This email was sent by: Bioscience Technology
100 Enterprise Drive - Suite 600 - Rockaway, NJ 07866-2129
© 2017 Bioscience Technology. All rights reserved.